Use of botulinum toxin as an adjuvant treatment in temporomandibular disorders and orofacial pain
DOI:
https://doi.org/10.33448/rsd-v12i7.42565Keywords:
Temporomandibular joint disorders; Botulinum toxins, type A; Temporomandibular joint dysfunction syndrome.Abstract
The objective of this study was to evaluate the use and effectiveness of botulinum toxin for the decline of symptoms that this dysfunction causes, through a case report of a patient with TMD in which two applications of botulinum toxin type A were performed by a qualified dental surgeon, clinical exams based on the Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) before the application and a 45-day follow-up after the first application to verify the result. It was verified that the action of Botulinum Toxins Type A (TXB-A) on the masseter and temporalis muscles significantly reduced the patient's symptoms right after the first application. In the second, only the masseter muscle received the toxin because it was still in pain. With the follow-up using the RDC/TMD, it was possible to verify the decay of the muscular symptoms, remaining only the joint TMD. Botulinum toxin type A is not a treatment of choice due to the controversies surrounding its use as a therapy, but rather an adjuvant treatment for the muscular symptoms of TMD, requiring further studies to assess the long-term result and, also, that the patient continues multidisciplinary treatments to take care of his/her TMD.
References
Barbosa, C. M. R. & Barbosa, J. R. A. (2017). Toxina botulínica em odontologia. Elsevier.
Bataglion, C., Bataglion, A., Bataglion, C. A. N &Bataglion, S. A. N. (2021).Disfunçãotemporomandibular na prática: diagnósticos e terapias. Manole.
Berry, M. G., &Stanek, J. J. (2012). Botulinumneurotoxin A: a review. Journalofplastic, reconstructive&aestheticsurgery: JPRAS, 65(10), 1283–1291. https://doi.org/10.1016/j.bjps.2012.04.016
Biasotto-gonzalez, D. A. (2005). Abordagem interdisciplinar das disfunçõestemporomandibulares. Manole.
Bicalho, M. B, Delgado, F. P. & Borini, C. B. (2015). Toxina botulínica no tratamento da disfunçãotemporomandibular. https://docplayer.com.br/53974356- Toxina-botulinica-no-tratamento-dadisfuncaotemporomandibular.html.
Bispo, L. B. (2019). A toxina botulínica como alternativa do arsenal terapêutico na odontologia.31(1): 74-87. Revista Odontologia da UNICID. ISSN 1983-5183. http://publicacoes.unicid.edu.br/index.php/revistadaodontologia/article/view/803/68.
Buosi, M. B., Fabrício, B., Ianeli, L. C., Carvalho, L. G., Olivo, J. Z. &Cubo, R. C. P. (2011). O uso da toxina botulínica na odontologia. Anais do fórum de iniciaçãocientífica do unifunec 2(2).https://seer.unifunec.edu.br/index.php/forum/article/view/289.
Buzalaf, M. A. R., Magalhães, A. C. & De Oliveira, R. C. (2022). Manual prático de Bioquímica Orofacial. (1st ed.). Manole.
Cavalcanti, M.O.A. (2014). Disfunção temporomandibular e dor orofacial em idosos: o impacto na qualidade de vida. Tese. Doutorado em Gerontologia Biomédica. Pontifícia Universidade Católica do Rio Grande do Sul.
Cazumbá, F. B., Sá, R. C., Kalil, M. T. A. C., Kalil, M. V. & Fernandes, G. V. O. (2017). Uso de Toxina Botulínica em Odontologia. Revista Fluminense de Odontologia, 1(47), 1-8. https://doi.org/10.22409/ijosd.v1i47.355
De Leeuw, R. & Klasser, G. D. (2013). Orofacial Pain: Guidelines for Assessment, Diagnosis, and Management.(5th ed.).Quintessence Publishing Co In.
Ferri, C. de F., Pissaia, P., Cavalheiro, S., Barbosa, B., Zen, A. S., Imanishi, S., Da Silva Muniz, M., & Dirschanabel, A. J. (2016). Toxina Botulínica na Odontologia. Ação Odonto, (1). https://periodicos.unoesc.edu.br/acaodonto/article/view/10515
Francescon, A. A. & Salles B. W. (2014). Uso da Toxina Botulínica no controle do Bruxismo. Trabalho de conclusão de curso (TCC) em odontologia. Universidade Federal de Santa Catarina.
Freitas, R. D. de, Abreu, B. A. de, Silveira, F. D., Fiamengui, L. M. S. P., Bezerra, M. M., & Chaves, H. V. (2023). Toxina botulínica no tratamento de pacientes com dor miofascial: uma revisão de escopo. Research, Society and Development, 12(4), e10312440996. https://doi.org/10.33448/rsd-v12i4.40996
Freitas Júnior, W. J. L. de, Marcos, Ângela M. da S., Maranhão, A. R. M., Lira, M. L. G. de O., Mendonça, G. L. de, Travassos, R. M. C., Cardoso, M. S. O., &Milhomens Filho, J. A. (2022). Toxina botulínica e Odontologia: revisão integrativa Research, Society and Development, 11(11), e561111134081. https://doi.org/10.33448/rsd-v11i11.34081
Guarda-Nardini, L., Manfredini, D., Salamone, M., Salmaso, L., Tonello, S., & Ferronato, G. (2008). Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study. Cranio: the journal of craniomandibular practice, 26(2), 126–135. https://doi.org/10.1179/crn.2008.017
Loureiro, J. M. V. C. (2013). Estudo dos distúrbios temporomandibulares numa população idosa institucionalizada. Monografia. Mestrado em Medicina Dentária. Universidade do Porto.
Manganello, L. C. S., Da Silveira, M. E. & Da Silva, A. A. F. (2014). ArticulaçãoTemporomandibular. Livraria Santos.
Pereira, A. S., Shitsuka, D. M., Parreira, F. J., &Shitsuka, R. (2018). Metodologia da pesquisa científica. UFSM. https://repositorio.ufsm.br/bitstream/handle/1/15824/Lic_Computacao_Metodologia-Pesquisa-Cientifica.pdf.
Plesh, O., Adams, S. H. & Gansky, S. A. (2011). Temporomandibular joint and muscle disorder-type pain and comorbid pains in a national US sample. Journalof orofacial pain, 25(3), 190-8. https://pubmed.ncbi.nlm.nih.gov/21837286/
Rao L. B., Sangur R. & Pradeep S. (2011). Aplicação de toxina botulínica tipo A: Um arsenal em odontologia. Journal indiana Dental Association,1 (22),440-445.
Ribeiro, D. L. & Mesquita, G. C. (2017). Toxina botulínica aplicada na odontologia para tratamento da disfunção temporomandibular. https://www.unirv.edu.br/conteudos/fckfiles/files/DANIELLE%20LOPES%20RIBEIR O%20.pdf.
Santos, M.M. (2021). Relação entre próteses parciais removíveis mal adaptadas e DTM: revisão de literatura.Trabalho de Conclusão de Curso (TCC) em Odontologia.Faculdade Maria Milza. http://famamportal.com.br:8082/jspui/bitstream/123456789/2380/1/ODONTOLOGIA%20%20MARIANA%20MIRANDA%20DOS%20SANTOS.pdf
Silva, G. C. da, Loureiro, A. M. S., Souza, C. T. de L., Silva, N. K. B., Lima, R. F. T. de ., Oliveira, T. B. B. de, & Cota, A. L. S. (2020). Uso da toxina botulínica no tratamento das desordens temporomandibulares: revisão integrativa. Research, Society and Development, 9(9), e589997491. https://doi.org/10.33448/rsd-v9i9.7491
Schiffman, E., Ohrbach, R., Truelove, E., Look, J., Anderson, G., Goulet, J. P., … Dworkin, S.F. Orofacial Pain Special Interest Group, International Association for the Study of Pain (2014). Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Group†. Journal of oral & facial pain and headache, 28(1), 6–27. https://doi.org/10.11607/jop.1151
Sposito, M. M. de M. & Teixeira, S. A. F. (2014). Toxina Botulínica Tipo A para bruxismo: análise sistemática. Acta Fisiátrica, 21(4):201-4. https://www.revistas.usp.br/actafisiatrica/article/view/103873.
Velázquez, M. F. et al. (2015). Desarrollo de miastenia gravis trasadministración de toxina botulínica en el síndrome de dolormio fascial. Revista Sociedad Española Del Dolor, 22(3), 102-105.https://dx.doi.org/10.4321/S1134-80462015000300003
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Ana Carla Leite Alberto Coelho; Angélica Brito Monteiro; Larissa Silva Peres; Pedro Augusto Peixoto Bittencourt; Roberta Mansur Caetano; Wesley Luis Rodrigues Pereira
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
